COMMUNIQUÉS West-GlobeNewswire
-
OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference
06/01/2026 -
Alumis Announces Proposed Public Offering of Common Stock
06/01/2026 -
ANI Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
06/01/2026 -
Anaptys to Present at the 44th Annual J.P. Morgan Healthcare Conference
06/01/2026 -
Dentsply Sirona to Present at the 44th Annual J.P. Morgan Healthcare Conference
06/01/2026 -
TeamBest Global Celebrates 16 Years of Cyclotron Innovation and Its Role in the Future of Theranostics
06/01/2026 -
Propr® Launches Clinically Inspired Toothbrush Designed to Protect Teeth, Heal Gums, and Redefine Daily Oral Care
07/01/2026 -
HUTCHMED Announces Positive Topline Results of Phase III Part of ESLIM-02 Trial of Sovleplenib for Warm Antibody Autoimmune Hemolytic Anemia in China
07/01/2026 -
Ziihera® (zanidatamab-hrii) Combinations Achieve Unprecedented Results in First-Line HER2+ Locally Advanced or Metastatic GEA including more than Two Years Median Overall Survival Benefit
06/01/2026 -
LifeLabs Named Canada’s Most Trusted Health Diagnostic Brand for Fourth Year in a Row
06/01/2026 -
SOUND Behavioral Health Chosen for Washington’s CCBHC Pre-Certification Cohort
06/01/2026 -
Beacon Behavioral Partners Enters 2026 Poised for Continued Growth Following Regional Expansion and Senior Leadership Additions
06/01/2026 -
Transactions of Managers and Closely Associated Persons
06/01/2026 -
Transactions of Managers and Closely Associated Persons
06/01/2026 -
Bright Minds Biosciences Announces Launch of US$100 Million Public Offering
06/01/2026 -
Praxis Precision Medicines, Inc. Announces Proposed Public Offering
06/01/2026 -
PridCor Therapeutics Advances SHIELD Study Through Dual Regulatory and Scientific Milestones With Peer-Reviewed Publication and FDA IND Exemption for Long COVID Program
06/01/2026 -
Teclison, Inc. to Participate in ASCO Gastrointestinal Cancers Symposium
06/01/2026 -
A Race Against Blindness Awards Additional $1.1 Million Grant to Ensure Advancement of AXV-101 into Clinical Trial for Bardet-Biedl Syndrome 1 (BBS1)
06/01/2026
Pages